2024-514713-35-00
Completed
Phase 1
A Phase I, open-label, fixed sequence drug interaction study in healthy subjects to investigate the effect of a 40 mg deucrictibant tablet administered once daily on the pharmacokinetics of the P-gp substrate digoxin and the BCRP substrate rosuvastatin, administered as a drug cocktail
Pharvaris Netherlands B.V.1 site in 1 country14 target enrollmentJuly 29, 2024
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Pharvaris Netherlands B.V.
- Enrollment
- 14
- Locations
- 1
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Active, Not Recruiting
Phase 1
A Phase 1 Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of STRO-002, an Anti-Folate Receptor alpha (FolRα) Antibody Drug Conjugate (ADC), in Combination with Bevacizumab in Patients with Advanced Epithelial Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers)2024-513708-33-00Sutro Biopharma Inc.20
Completed
Phase 1
A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight SubjectsNCT07269756Shandong Suncadia Medicine Co., Ltd.40
Active, Not Recruiting
N/A
A Study to Learn if a Medicine That Reduces Stomach Acid Affects the Blood Level of Study Medicine PF-08049820 in Healthy Chinese Adults.NCT07284173Pfizer18
Recruiting
Phase 1/2
Clinical trial of MDNA11 (investigational drug) administered alone or in combination with pembrolizumab (immune checkpoint inhibitor) in Patients with Advanced Solid Tumors2023-507536-21-00Medicenna Therapeutics Inc.50
Not Yet Recruiting
N/A
Pharmacokinetics, Safety, and Tolerability of GOPRELTO and NUMBRINO in Pediatric Nasal ProceduresNCT07287735Omnivium Pharmaceuticals LLC40